TMDX TransMedics Group PE ratio, current and historical analysis

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 93

As at Jul 24, 2026, the TMDX stock has a PE ratio of 14.31. This is based on the current EPS of $5.05 and the stock price of $72.26 per share. A decrease of 61% has been recorded in the P/E ratio compared to the average of 36.4 of the last 4 quarters.

TMDX PE ratio history

How has TMDX's PE ratio performed in the past

The mean historical PE ratio of TransMedics Group over the last three years is 286.39. The current 14.31 PE ratio is 95% below the historical average. In the past three years, TMDX's PE ratio was at its highest in the Jun 2024 quarter at 1,882.75, with a price of $150.62 and an EPS of $0.08. The Mar 2026 quarter recorded the bottom point at 19.69, with a price of $99.41 and an EPS of $5.05.

Today
14.31
Average
286.39
Median
52.02
Minimum
19.69
Maximum
1,882.75

TransMedics Group PE ratio by year

Maximum annual decrease: -62.73% in 2025

Year PE ratio PE change Price EPS
2025 21.72 -62.73% $121.65 $5.6
2024 58.27 N/A $62.35 $1.07
2023 N/A N/A $78.93 -$0.77
2022 N/A N/A $61.72 -$1.23
2021 N/A N/A $19.16 -$1.6
2020 N/A N/A $19.9 -$1.16
2019 N/A N/A $18.59 -$2.36
2018 N/A N/A N/A -$17.48
2017 N/A N/A N/A -$4.48
2016 N/A N/A N/A -$5.35

TransMedics Group PE ratio by quarter (TTM)

Year PE ratio PE change Price EPS
Mar 2026 19.69 -9.35% $99.41 $5.05
Dec 2025 21.72 -47.54% $121.65 $5.6
Sep 2025 41.4 -34.2% $112.2 $2.71
Jun 2025 62.92 37.47% $134.01 $2.13
Mar 2025 45.77 -21.45% $67.28 $1.47
Dec 2024 58.27 -63.26% $62.35 $1.07
Sep 2024 158.59 -91.58% $157 $0.99
Jun 2024 1,882.75 N/A $150.62 $0.08
Mar 2024 N/A N/A $73.94 -$0.32
Dec 2023 N/A N/A $78.93 -$0.77
Sep 2023 N/A N/A $54.75 -$1.09
Jun 2023 N/A N/A $83.98 -$0.56
Mar 2023 N/A N/A $75.73 -$0.94
Dec 2022 N/A N/A $61.72 -$1.23
Sep 2022 N/A N/A $41.74 -$1.5

TMDX Price vs fair value

How does TMDX's price compare to its estimated fair value based on its growth

TMDX average PE ratio chart

What is the average PE ratio of TMDX for the past years

Currently, TMDX's PE ratio is lower than the 3 and 5-year averages.

3-year avg
286.39
5-year avg
286.39
10-year avg
N/A
15-year avg
N/A

PE comparison

With a P/E of 14.31, TMDX stands below the Healthcare sector and the industry average. Compared to its Healthcare sector average of 25.31, TransMedics Group's P/E is 43% lower.

TMDX PE vs peers

What is TMDX's PE ratio compared to its peers
Stock name PE ratio Market cap
TMDX TransMedics Group Inc 14.31 $2.5B
OBIO Orchestra BioMed Holdings Inc N/A $223.95M
OM Outset Medical Inc N/A $74.89M

Frequently asked questions

What is TransMedics Group's PE ratio?

As of Jul 24, 2026, TMDX stock has a price to earnings ratio of 14.31.

What is the 3-year average PE ratio for TransMedics Group (TMDX)?

The 3-year average PE ratio for TMDX stock is 286.39.

What is the 5-year average PE ratio for TransMedics Group (TMDX)?

The 5-year average PE ratio for TMDX stock is 286.39.

What is the highest PE ratio for TMDX?

Over the last three years, the quarterly PE ratio reached a historic high of 1,882.75 in the Jun 2024 quarter.

How does the current PE ratio for TMDX compare to its historical average?

TMDX's current price to earnings ratio is 95% below its 3-year historical average.

How is TMDX's PE ratio calculated (TransMedics Group PE ratio formula)?

You can calculate the PE ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Jul 24, 2026), TransMedics Group's stock price is $72.26. The earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $5.05. Therefore, TransMedics Group's P/E ratio for today is 14.31. PE RATIO(14.31) = STOCK PRICE($72.26) / TTM EPS($5.05)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.